Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1)
Inactivators of plasminogen activator inhibitor-1 (PAI-1) have been identified as possible treatments for a range of conditions, including atherosclerosis, venous thrombosis, and obesity. We describe the synthesis and inhibitory activity of a novel series
El-Ayache, Nadine C.,Li, Shih-Hon,Warnock, Mark,Lawrence, Daniel A.,Emal, Cory D.
supporting information; experimental part
p. 966 - 970
(2010/06/16)
More Articles about upstream products of 185300-48-5